Hi-Tech Pharmaceuticals Recalls All Lots of Stamina-Rx Dietary Supplement Products
June 17, 2009
Norcross, GA – Hi-Tech Pharmaceuticals, Inc. (”Hi-Tech”), 6015-B Unity Dr., Norcross, GA 30071, announced today that it is conducting a nationwide voluntary recall of the company’s product sold under the name Stamina-Rx.
Zicam Recall Information
June 16, 2009
UPDATE: A Zicam recall is being conducted voluntarily by Matrixx, makers of Zicam Cold Remedy products.
FDA is warning consumers about certain Zicam products and a troubling potential side effect: loss of sense of smell.
FoodScience Corporation Recalls Kid’s Multivitamin for Label Error
June 10, 2009
FoodScience Corporation of Essex Junction, Vermont 05452 is voluntarily recalling a total of approximately 1,250 bottles of its Children’s Multi Vitamins.
Fun Express Expands Recall of Water-Based Face Paint
June 4, 2009
Fun Express, Inc. has expanded its May 12, 2009 recall of face paint items to include two additional face paint colors. The face paints may cause skin irritation, rashes and itchiness. The additional two face paint items are being removed from the marketplace as a precautionary measure.
Roche Diagnostics notifies customers of the potential for ACCU-CHEK Softclix 10 and/or 17 count lancets to be uncapped which may lead to an accidental needle stick
June 4, 2009
AS Medications Solution Recalls All Lots of Digoxin Tablets 0.25mg Due to Size Variability
June 4, 2009
A S Medication Solutions, LLC, a drug repackage company, announced that all tablets of Caraco brand Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of August, 2011, are being voluntarily recalled. The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin.
Iovate Health Sciences U.S.A., Inc. Adds Hydroxycut-Branded Product Universal Product Codes to Nationwide Recall
June 4, 2009
See this article for more information on the nationwide Hydroxycut product recall.
Biosite Incorporated Issues Voluntary, Nationwide Recall for Cardiac Marker Test
June 4, 2009
Fun Express Expands Nationwide Recall of Water-Based Face Paint
May 23, 2009
CONTACT: ANGELA D. DREW 402-596-2647
FUN EXPRESS, INC. HAS EXPANDED ITS MAY 12, 2009 RECALL OF FACE PAINT ITEMS TO INCLUDE TWO ADDITIONAL FACE PAINT COLORS. THE FACE PAINTS MAY CAUSE SKIN IRRITATION, RASHES AND ITCHINESS. THE ADDITIONAL TWO FACE PAINT ITEMS ARE BEING REMOVED FROM THE MARKETPLACE AS A PRECAUTIONARY MEASURE.
FDA Alerts Consumers to Recall of Water-Based Face Paints
May 13, 2009
THE FOOD AND DRUG ADMINISTRATION IS ADVISING CONSUMERS TO STOP USING CERTAIN COSMETIC “FACE PAINT” ITEMS LABELED AS DISTRIBUTED BY ORIENTAL TRADING CO., OMAHA, NEB., DUE TO ADVERSE EVENT REPORTS OF SKIN REACTIONS IN CHILDREN. THESE ITEMS WERE DISTRIBUTED NATIONWIDE.
Iovate Health Sciences Adds Hydroxycut-Branded Product Universal Product Codes to Recall
May 10, 2009
CONTACT: JAMIE MOSS 201-493-1027
IOVATE HEALTH SCIENCES USA, INC. OF BLASDELL, NEW YORK AND ONTARIO, CANADA ANNOUNCED TODAY THAT IT IS ADDING UNIVERSAL PRODUCT CODES (UPCS) WITH RESPECT TO THE RECALLED HYDROXYCUT-BRANDED PRODUCTS SOLD IN THE UNITED STATES. THESE ADDITIONS ALL INVOLVE ADDITIONAL PACKAGES AND SIZES OF PRODUCTS PREVIOUSLY REFERENCED.
Biosite Incorporated Recalls Cardiac Marker Test
May 7, 2009
CONTACT: CARMEN BERGELIN (858) 805-2256
Iovate Health Sciences U.S.A., Inc. Recalls Hydroxycut Products
May 5, 2009
CONTACT: JAMIE MOSS 201-493-1027
IOVATE HEALTH SCIENCES USA, INC. OF BLASDELL, NEW YORK AND ONTARIO, CANADA ANNOUNCED TODAY THAT IT IS VOLUNTARILY RECALLING HYDROXYCUT BRANDED PRODUCTS SOLD IN THE UNITED STATES.
Disetronic Medical Systems Recalls ACCU-CHEK Spirit Insulin Pumps
May 1, 2009
CONTACT: JULIE VINCENT 317-521-1910
FOR IMMEDIATE RELEASE — APRIL 30, 2009 — THIS NOTIFICATION APPLIES TO ALL ACCU-CHEK® SPIRIT INSULIN PUMPS WITH SERIAL NUMBERS FROM SN02119552 THROUGH SN10006093 (RANGE OF SN SHIPPED TO THE US). PUMPS WITH SERIAL NUMBERS INCLUDING AND ABOVE SN10006094 ARE NOT AFFECTED AND NO ACTION IS REQUIRED BY USERS OF THESE PUMPS.
Nature and Health Recalls Libimax Because it Contains Pharmacutical Ingredients for Erectile Dysfunction
April 30, 2009
CONTACT: BOKSIK (AKA ROBERT) KIM (714) 257-1800
Personal Care Products Conducts Nationwide Recall of Non-Acetone Nail Polish Remover
April 30, 2009
CONTACT: LAWRENCE WEISBERG 248-258-1555
FOR IMMEDIATE RELEASE — APRIL 29, 2009 — PERSONAL CARE PRODUCTS OF BINGHAM FARMS, MI IS VOLUNTARILY CONDUCTING A NATIONWIDE RECALL OF ALL LOTS OF PERSONAL CARE NON-ACETONE NAIL POLISH REMOVER, CONDITIONER ENRICHED WITH GELATIN, 6 FL. OZ., UPC 4815592076, BECAUSE IT DOES NOT MEET PRODUCT SPECIFICATIONS AND HAS THE POTENTIAL TO CAUSE CHEMICAL BURNS TO THE FINGERS OF USERS.
Recall Of Prescription Cough and Cold Drugs by Neilgen Pharma and Advent Pharmaceutical
April 22, 2009
CONTACT: BHARAT PATEL, PRESIDENT (609) 448-5500
NEILGEN PHARMA INC. OF WESTMINSTER, MD AND ADVENT PHARMACEUTICAL OF EAST WINDSOR, NJ ARE RECALLING ALL PRESCRIPTION COUGH AND COLD DRUG PRODUCTS SOLD ON OR AFTER MARCH 5, 2008. NEILGEN PHARMA AND ADVENT PHARMACEUTICAL ARE CONTRACT MANUFACTURERS FOR THESE PRODUCTS AND ARE RECALLING THE LISTED PRODUCTS BELOW DUE TO THE UNAPPROVED DRUG PRODUCT CATEGORY.
ION Labs Inc. Recalls Influend Cough and Cold Products, in Alabama
April 17, 2009
ION LABS INC. OF CLEARWATER, FL. IS VOLUNTARILY RECALLING ALL OF THE INFLUEND COUGH AND COLD PRODUCTS SOLD ON OR AFTER MAY 30, 2008. ION LABS INC. IS RECALLING THE LISTED PRODUCTS DUE TO THE PRODUCTS NOT TESTED IN CONFORMANCE WITH THE SPECIFICATIONS OF THE LAB, THEREFORE THE PRODUCTS MAY HAVE A POSSIBILITY TO BE SUPER POTENT. POSSIBLE COMPLICATIONS MAY INCLUDE TACHYCARDIA, PALPITATIONS, ARRHYTHMIAS, CARDIOVASCULAR COLLAPSE WITH HYPOTENSION, HEADACHES, DIZZINESS, ANXIETY, RESTLESSNESS AND NERVOUSNESS. THE FOLLOWING PRODUCTS WERE DISTRIBUTED AND SOLD DIRECTLY TO CONSUMERS IN THE MADISON/HUNTSVILLE, ALABAMA AREA:
Class I Recall of Intra Aortic Balloon Pump (IAB) Catheters by Arrow International
April 15, 2009
CONTACT: INVESTORS:  JAKE ELGUICZE   610-948-2836 MEDIA:    JULIE MCDOWELL    610-948-2829
FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. Market
April 9, 2009
GENENTECH, THE MANUFACTURER OF THE PSORIASIS DRUG RAPTIVA (EFALIZUMAB), ANNOUNCED THAT IT HAS BEGUN A VOLUNTARY, PHASED WITHDRAWAL OF RAPTIVA FROM THE U.S. MARKET. THE COMPANY IS TAKING THIS ACTION BECAUSE OF A POTENTIAL RISK TO PATIENTS OF DEVELOPING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML), A RARE, SERIOUS, PROGRESSIVE NEUROLOGIC DISEASE CAUSED BY A VIRUS THAT AFFECTS THE CENTRAL NERVOUS SYSTEM. BY JUNE 8, 2009, RAPTIVA WILL NO LONGER BE AVAILABLE IN THE UNITED STATES.
-
Sponsors
